26 January, 2024
We warmly welcomed a 6-member Bhutan Food and Drug Authority team as they visited our ABHL plant for the GMP certificate renewal audit from January 24-26, 2024. We are excited to announce the audit's success, reaffirming our commitment to excellence. To mark this milestone, we captured memorable moments with the BFDA team during their visit and are grateful to the BFDA team for their meticulous evaluation and collaboration. We are delighted that collaboratively, we are paving the way for excellence in the pharmaceutical industry!
24 February, 2024
Transforming Bhutan’s Healthcare Azista Bhutan Healthcare Limited Leads the Charge Thimphu, Bhutan24 February, 2024
Team Blood Donation Drive28 December, 2024
A Plant Visit Recap - ABHL Hosts DHI Group's Menjong Sorig7th June 2025
Azista Bhutan Healthcare Limited had the honour of meeting the Hon'ble Prime Minister of Bhutan,
Dasho Tshering Tobgay, to discuss the future of pharmaceutical innovation in the region.
Led by CEO Mr. Obula Reddy, the meeting focused on Azista Bhutan's
ongoing efforts to strengthen local manufacturing
and our long-term strategy to expand exports to third countries between
FY 2025 - 28. We shared progress on our pharmaceutical plant, which is already accredited by
BFDA, Turkey, Yemen, and Cambodia, and highlighted our
active engagements with the East African Community and EU nations.
Prime Minister Tobgay's insightful understanding of the healthcare ecosystem and his strong encouragement reaffirmed
our mission. His support for local industry and innovation inspires our commitment to contribute meaningfully to
Bhutan's healthcare resilience and regional impact.
Tashi Delek to the Hon'ble Prime Minister for his vision and steadfast support.
To order or to know more details about Menthopas, reach us by filling the form. We will get back you within 1-2 business days.